OEMINE ARTER
Food supplement declared in France, declaration No 2024-7-1115, decision dated 17 July 2024
OEMINE ARTER (OEMINE) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- OEMINE
- Food business operator placing the product on the market
- PHYBIO PHARMA
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 6 gélules
- Directions for use
- 2 gélules matin et soir
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes, Maladie rénale, Problèmes cardiaques, Sous anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Artères et cholestérol
Declaration 308689, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Olea europaea subsp. europaea | Feuille | Extrait sec aqueux | 988 mg |
| Allium sativum L. | Bulbe | Extrait sec aqueux | 544 mg |
| Vitis vinifera L. | Feuille | Extrait sec aqueux | 544 mg |
Additives
E1204
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
En cas de prise de médicaments, demandez conseil à votre médecin. En cas de prise de médicaments, demandez conseil à votre médecin. déconseillé aux femmes enceintes et allaitantes et en cas de traitement concomitant par un médicament anti-rétroviral (saquinavir, ritonavir,…), anticoagulants ou antiagrégants plaquettaires, en cas d'insuffisance cardiaque ou rénale. Réservé à l'adulte.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- OEMINE ARTER OEMINE, declared in 2023, withdrawal announced : different composition: 1 ingredient(s) added, 0 missing
Brand : OEMINE